COAGULATION SYSTEM (PART II) Flashcards
Hemostasis Specimen Collection
Blue-top or blue-stopper
Blue-top or blue-stopper buffered _____ (3.2%) sodium citrate
0.105 to 0.109 M
It reversibly binds calcium ions to prevent coagulation .
Sodium citrate
The specimen must be collected first or immediately after a
non-additive tube
Ratio of blood to anticoagulant
9:1 or
2.7 ml (blood) to 0.3 ml (anticoagulant)
IF patient’s hematocrit is 55%
C=(1.85x10^-3) (100-HCT) V
C in the formula is
sodium Citrate in milliliters
V is
Volume of whole blood-sodium citrate solution in milliliters
HCT
hematocrit in percent (%)
1.85 x 10-3 is
constant
EDTA should __ be used. EDTA____chelates calcium ions
Not, irreversibly
Specimen collection errors
Short draw
Specimen clot
Visible hemolysis
Lipemia or icterus
Tourniquet more than 1min
Specimen storage at 1-6c
Specimen storage at greater than 25C
Must be tested within 24 hours
of the time of collection
PT
Must be tested within 4 hours
of the time of collection
For APTT
Platelet Function Tests
- Bleeding Time Test
- Von Willebrand Factor Activity Assays
- Platelet Aggregometry
- Heparin-Induced Thrombocytopenia Assays
Was the original test of platelet function (now obsolete). First described by Duke. Modified by Ivy
Bleeding Time Test
BP cuff inflated at 40 mmHg; incisions made on the volar surface of the forearm; blotted
every 30 seconds)
Bleeding Time Test
Requires a panel of quantitative and functional assays and these include: VWF antigen (VWF:Ag) immunoassay, Clot-based coagulation factor VII assay, Functional VWF ristocetin cofactor assay (VWF:RCo),Dilute ristocetin-induced platelet aggregation assay
(RIPA)
Von Willebrand Factor Activity Assays
Von Willebrand Factor Activity Assays. Requires a panel of quantitative and functional assays and these include:
○ VWF antigen (VWF:Ag) immunoassay
○ Clot-based coagulation factor VII assay
○ Functional VWF ristocetin cofactor assay (VWF:RCo)
○ Dilute ristocetin-induced platelet aggregation assay (RIPA)
A. Platelet aggregometry with Platelet-Rich Plasma (PRP)
B. Whole blood platelet aggregometry
C. Platelet lumiaggregometry
Platelet Aggregometry
Clot-Based Screening Tests for Coagulation
Disorders
- Prothrombin time
- Partial Thromboplastin time
- PTT mixing studies
- Thrombin clotting time
- Venom Activated assays
Was the first laboratory procedure designed to assess coagulation
Lee-White Whole Blood Coagulation Time Test
Lee-White Whole Blood Coagulation Time Test principle?
The time interval from the initiation of clotting to visible clot formation reflects the condition of the coagulation mechanism
Lee-White Whole Blood Coagulation Time Test was modified to?
Activated Clotting Time (ACT) Test